275 related articles for article (PubMed ID: 25963433)
1. The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.
Yousefi M; Movassaghpour AA; Shamsasenjan K; Ghalamfarsa G; Sadreddini S; Jadidi-Niaragh F; Hojjat-Farsangi M
Future Oncol; 2015; 11(10):1567-82. PubMed ID: 25963433
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.
Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
Leuk Lymphoma; 2015; 56(8):2424-8. PubMed ID: 25393804
[TBL] [Abstract][Full Text] [Related]
3. Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia.
Pang N; Zhang R; Li J; Zhang Z; Yuan H; Chen G; Zhao F; Wang L; Cao H; Qu J; Ding J
Int Immunopharmacol; 2016 Nov; 40():57-64. PubMed ID: 27584054
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias.
Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
Leuk Lymphoma; 2013 May; 54(5):1012-9. PubMed ID: 23009220
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.
Perry C; Herishanu Y; Hazan-Halevy I; Kay S; Bdolach N; Naparstek E; Polliack A; Grisaru D
Leuk Lymphoma; 2012 Sep; 53(9):1807-10. PubMed ID: 22242820
[No Abstract] [Full Text] [Related]
6. IL-33 changes CD25
Park SH; Jung HJ; Kim TS
Immunol Lett; 2020 Feb; 218():5-10. PubMed ID: 31863784
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells and T helper 17 cells in viral infection.
Wan Z; Zhou Z; Liu Y; Lai Y; Luo Y; Peng X; Zou W
Scand J Immunol; 2020 May; 91(5):e12873. PubMed ID: 32090360
[TBL] [Abstract][Full Text] [Related]
8. The deviated balance between regulatory T cell and Th17 in autoimmunity.
Jadidi-Niaragh F; Mirshafiey A
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):727-39. PubMed ID: 22316060
[TBL] [Abstract][Full Text] [Related]
9. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients.
Zhao C; Chu Y; Liang Z; Zhang B; Wang X; Jing X; Hao M; Wang Y; An J; Zhang X; Sun L; Chen J
BMC Immunol; 2019 Sep; 20(1):32. PubMed ID: 31484501
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
11. Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation.
Jang SW; Hwang SS; Kim HS; Lee KO; Kim MK; Lee W; Kim K; Lee GR
Exp Mol Med; 2017 Sep; 49(9):e375. PubMed ID: 28883547
[TBL] [Abstract][Full Text] [Related]
12. [TIM-3/galectin-9 is involved in negative regulation of T cells in patients with chronic lymphocytic leukemia].
Xierenguli A; Zeng X; Pang N; Zhagn R; Ma J; Zhao Y; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1021-1025. PubMed ID: 33210597
[TBL] [Abstract][Full Text] [Related]
13. Th17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity.
Hus I; Bojarska-Junak A; Chocholska S; Tomczak W; Woś J; Dmoszyńska A; Roliński J
PLoS One; 2013; 8(11):e78091. PubMed ID: 24223764
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
15. Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes.
Ryba-Stanisławowska M; Skrzypkowska M; Myśliwiec M; Myśliwska J
Hum Immunol; 2013 Jun; 74(6):701-7. PubMed ID: 23395729
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.
Jadidi-Niaragh F; Ghalamfarsa G; Memarian A; Asgarian-Omran H; Razavi SM; Sarrafnejad A; Shokri F
Tumour Biol; 2013 Apr; 34(2):929-40. PubMed ID: 23269607
[TBL] [Abstract][Full Text] [Related]
17. An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia.
Wallace ME; Alcantara MB; Minoda Y; Kannourakis G; Berzins SP
Int Immunopharmacol; 2015 Oct; 28(2):897-900. PubMed ID: 25862133
[TBL] [Abstract][Full Text] [Related]
18. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.
Szodoray P; Nakken B; Barath S; Csipo I; Nagy G; El-Hage F; Osnes LT; Szegedi G; Bodolay E
Hum Immunol; 2013 Dec; 74(12):1510-8. PubMed ID: 23974054
[TBL] [Abstract][Full Text] [Related]
19. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy.
Qianmei Y; Zehong S; Guang W; Hui L; Lian G
Immunol Res; 2021 Oct; 69(5):398-414. PubMed ID: 34302619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
